Status:
COMPLETED
Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome
Lead Sponsor:
Hospital Privado de Cordoba, Argentina
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
Polycystic ovary syndrome is a frequent cause of abnormal menses and infertility. It has also been related to cardiovascular disease. The objective of this trial is to evaluate the clinical and metab...
Detailed Description
Polycystic ovary syndrome (PCOS) is a common and heterogeneous disorder of women in reproductive age. It is characterized by hyperandrogenism and chronic anovulation. Several studies in diverse popula...
Eligibility Criteria
Inclusion
- Women in reproductive age
- With polycystic ovary syndrome defined by hyperandrogenism (elevated serum testosterone concentrations), and oligomenorrhea (cycles of 35 days or longer), or amenorrhea (no menses in the last 6 months) after negative screening pregnancy test
Exclusion
- Pregnancy
- Cushing' s syndrome
- Late onset congenital adrenal hyperplasia
- Androgen-secreting tumors
- Uncontrolled thyroid disease
- Hyperprolactinemia
- Diabetes any
- Cardiovascular diseases (Ischaemic heart disease, uncontrolled hypertension, heart failure)
- Acute or chronic infections at baseline
- Renal disease
- Liver disease
- Had taken any medications for at least 3 months before enrolment in the study.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00679679
Start Date
January 1 2003
End Date
December 1 2005
Last Update
May 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Privado de Córdoba
Córdoba, Córdoba Province, Argentina, X5016KEH